• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC141400
Device Problems Premature Activation (1484); Material Separation (1562)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/13/2014
Event Type  malfunction  
Event Description
On (b)(6) 2014, the patient underwent treatment of an abdominal aortic aneurysm with gore® excluder® aaa endoprostheses.Pre-operative images reportedly identified heavily calcified and tortuous anatomy distal to the landing zone.It was reported a contralateral leg component was advanced outside of the sheath, rotated, and torqued excessively in an attempt to advance the device into the contralateral gate.When this reportedly proved unsuccessful, a left brachial approach was attempted to snare the contralateral leg component and pull it through the gate.It was reported that the graft was snared, but when the device was pulled into the gate, the device prematurely deployed ~1cm distal to the contralateral gate.Angiography reportedly showed the leading olive and part of the polyimide wire had separated from the delivery catheter and now remained within the contralateral gate and the contralateral leg component.The detached olive and polyimide wire were snared and removed from the patient, and an additional device was implanted to bridge the trunk-ipsilateral and contralateral leg components.Final angiography showed exclusion of the aneurysm, and the patient tolerated the procedure.
 
Manufacturer Narrative
Patient medications include pepcid, spiriva, zoloft, metoprolol, lisinopril, flovent, docusate, lipitor, aspirin, plavix, albuterol, tylenol, milk of magnesia and hydrocodone.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
Evaluation summary: the device and delivery catheter were returned to gore for evaluation.The guidewire and the introducer sheath were not returned and therefore unavailable for evaluation.Based on the available information and evaluation of the returned product, no root cause could be determined.However, use outside of the instructions for use was noted and may have contributed to this event.The root cause of the event could not be determined with the provided information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3658555
MDR Text Key4353263
Report Number2953161-2014-00026
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2016
Device Catalogue NumberPXC141400
Device Lot Number12109549
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/19/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/04/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/24/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/30/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age74 YR
Patient Weight85
-
-